ActiveGRANT

DoW Toxic Exposures Clinical Trial Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This award supports clinical trials investigating health outcomes and treatments for service members exposed to toxic substances during military operations. The research aims to establish evidence-based interventions and improve medical care for affected veterans.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 21, 2026
Due Date
November 19, 2026

Official Description

<p><strong>Summary:</strong> The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human,...
View on official source

Change History

Field UpdatedMay 21, 2026 at 9:07 PM

DoW Toxic Exposures Clinical Trial Award

This funding opportunity provides unrestricted grants open to any entity type for science and technology research and development, with no cost-sharing requirement, and inquiries directed to help@eBRAP.org.

Description ChangedMay 21, 2026 at 9:07 PM

DoW Toxic Exposures Clinical Trial Award

This FY26 funding mechanism supports clinical trials addressing military-related toxic exposures, ranging from proof-of-concept to large-scale efficacy studies, with a distinctive Partnering PI Option that funds interdisciplinary collaborations between clinicians and researchers as separate awards.

Date ChangedMay 21, 2026 at 9:07 PM

DoW Toxic Exposures Clinical Trial Award

Close Date changed from None to 2026-11-19 00:00:00+00:00

Status ChangedMay 21, 2026 at 9:07 PM

DoW Toxic Exposures Clinical Trial Award

Status changed from forecast to open

Opportunity AddedMay 7, 2026 at 4:44 PM

DoW Toxic Exposures Clinical Trial Award

New Grants.gov opportunity: DoW Toxic Exposures Clinical Trial Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial